Skip to content

RAP and BEAT Clinical Trial (Radial Artery Patency and Bleeding, Effectiveness, Adverse evenT Trial)

RAP and BEAT Clinical Trial (Radial Artery Patency and Bleeding, Effectiveness, Adverse evenT Trial) - RAP and BEAT

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42483
Enrollment
300
Registered
2016-01-14
Start date
2016-02-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

radial artery occlusion occlusie van de a. radialis

Interventions

receive GSS 6Fr sheath (950 patients) or SOC 5Fr sheath (950 patients).

Sponsors

NPO International TRI Network, Research Center, Cardiovascular Dept., Shonan Kamakura General hospital
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 5.4 General Inclusion Criteria 1. Patient must be at least 18 years of age. 2. Patient is able to verbally acknowledge an understanding of the associated risks, benefits and treatment alternatives 3. Patient who is expected to diagnose by coronary artery angiography or followed by PCI. 4. Patient must agree to undergo all protocol-required follow-up examinations. 5. Patient who can accept radial access.

Exclusion criteria

Exclusion criteria: 1. Patient has other medical illness (e.g., cancer or congestive heart failure) that may cause non-compliance with the protocol, confound the data interpretation or is associated with a limited life expectancy (i.e., less than one year). 2. Hemodialysis patient 3. STEMI

Design outcomes

Primary

MeasureTime frame
The primary endpoint is composite of the freedom from radial artery occlusion (RAO) and local bleeding from the puncture site at the time of discharge or the next day, the earlier of the two.

Secondary

MeasureTime frame
Procedure success rate at the index procedure. * Vascular access site complication * Radial spasm during the index procedure. * Total Procedure Time * Total Amount of Contrast Dye * Fluoroscope time * Procedure failure due to the assigned sheath. * Pain score

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)